KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Liabilities (2016 - 2026)

AbbVie has reported Total Liabilities over the past 14 years, most recently at $137.2 billion for Q4 2025.

  • Quarterly Total Liabilities rose 4.12% to $137.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.2 billion through Dec 2025, up 4.12% year-over-year, with the annual reading at $137.2 billion for FY2025, 4.12% up from the prior year.
  • Total Liabilities was $137.2 billion for Q4 2025 at AbbVie, up from $136.5 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $140.8 billion in Q1 2024 and troughed at $121.2 billion in Q1 2023.
  • The 5-year median for Total Liabilities is $133.2 billion (2024), against an average of $131.2 billion.
  • Year-over-year, Total Liabilities skyrocketed 38.69% in 2021 and then decreased 7.38% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $131.1 billion in 2021, then dropped by 7.3% to $121.5 billion in 2022, then increased by 2.3% to $124.3 billion in 2023, then increased by 6.02% to $131.8 billion in 2024, then rose by 4.12% to $137.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Total Liabilities are $137.2 billion (Q4 2025), $136.5 billion (Q3 2025), and $137.3 billion (Q2 2025).